Polymorphic N-acetylation of a caffeine metabolite

Clin Pharmacol Ther. 1983 Mar;33(3):355-9. doi: 10.1038/clpt.1983.45.

Abstract

In the course of investigations into variability in the metabolism of caffeine in human populations, urinary levels of 5-acetylamino-6-formylamino-3-methyluracil (AFMU), a newly discovered ring-opened metabolite of caffeine, were found to be both bimodally distributed and interethnically variable in samples (Caucasian: n = 42; Oriental: n = 26) from the Toronto population. To test the premise that the polymorphic N-acetyltransferase enzyme (E.C.2.3.1.5) could be responsible for the production of AFMU, 20 of the subjects were phenotyped for acetylator status using sulfamethazine (SMZ). Concordance for all subjects between AFMU production and SMZ acetylation strongly suggests that the acetylation polymorphism is involved in the formation of AFMU in man.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Acetyltransferases / metabolism
  • Adolescent
  • Adult
  • Aged
  • Asian Continental Ancestry Group
  • Caffeine / metabolism*
  • Chromatography, High Pressure Liquid
  • European Continental Ancestry Group
  • Female
  • Humans
  • Male
  • Middle Aged
  • Phenotype
  • Polymorphism, Genetic*
  • Sulfamethazine / metabolism
  • Uracil / analogs & derivatives*
  • Uracil / urine

Substances

  • Caffeine
  • Sulfamethazine
  • Uracil
  • 5-acetylamino-6-formylamino-3-methyluracil
  • Acetyltransferases